Ebumab

Copenhagen, Denmark

Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.

$495K raised

Sep 2022

Convertible Note

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ebumab raised?

Ebumab has raised $495K in total funding. The most recent round was Convertible Note. The last funding was announced in September 2022.

Who are Ebumab's investors?

Ebumab's investors include BioInnovation Institute.

Where is Ebumab headquartered?

Ebumab is headquartered in Copenhagen, Denmark.

What does Ebumab do?

Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.

What stage is Ebumab at?

Ebumab is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 6, 2022.

MLA

"Ebumab — Funding & Investors." VCBacked, September 6, 2022, https://www.vcbacked.co/company/ebumab. Accessed July 2, 2026.

APA

VCBacked. (2022). Ebumab — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ebumab

Wikipedia (cite web)

{{cite web |title=Ebumab — Funding & Investors |url=https://www.vcbacked.co/company/ebumab |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 6, 2022.